Partnering for Success: the Pioneers of Affordable CAR-T Cell/Gene Therapy for Leukemias and Lymphomas.

ImmunoACT Logo 1

ImmunoAct

ImmunoACT is pioneering the first affordable cell and gene therapies in India for patients’ long-term cures through translational research and beyond. CAR-T cell therapies are highly effective in curing certain type of Cancers Leukemia and Lymphoma.

Challenges:

The Customer is a clinical-stage biopharmaceutical company making strategic investments to complete Phase I & Phase II trials cost effectively to prepare for Phase III clinical trials. The customer has setup a team for clinical operations in-house and sought a secure, compliant, easy to use software solution that can accelerate their clinical development timelines without having to tap into a large full service CRO or without in-house IT infrastructure.

Jeeva eClinical Cloud Final

Jeeva Solution

Jeeva eClinical Cloud software solution aided the ImmunoACT clinical operations team and clinical trial investigator team at the Tata Memorial Centre in accurate and faster patient screening, enrollment, and electronic data capture of high-quality, compliant, clinical trial data from persons with Leukemia and Lymphoma enrolled at five centers across India. The software enables faster, cheaper, and better ways to execute Phase II trial.